Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,820.00
+30.00 (0.34%)
Last updated: Apr 29, 2026, 2:20 PM KST
Market Cap243.29B +183.5%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio145.68
Forward PEn/a
Dividend30.00 (0.33%)
Ex-Dividend DateMar 3, 2026
Volume316,168
Average Volume417,597
Open8,800.00
Previous Close8,790.00
Day's Range8,540.00 - 8,840.00
52-Week Range3,260.00 - 15,960.00
Beta0.96
RSI50.20
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements